Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancers|August 26, 2023
Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at DiagnosisSara Montesdeoca, Nieves García-Gisbert, Xavier Calvo, et al.
American Journal of Hematology|April 30, 2025
Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome MappingRashmi Kanagal-Shamanna, Anna Puiggros, Isabel Granada, et al.
Experimental Hematology|January 9, 2021
Chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemiaGonzalo Blanco, Anna Puiggros, Barbara Sherry, et al.
British Journal of Haematology|January 10, 2012
Chronic lymphocytic leukaemia with 17p deletion: a retrospective analysis of prognostic factors and therapy resultsJulio Delgado, Blanca Espinet, Ana C Oliveira, et al.
Cancers|July 27, 2022
Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)Anna Puiggros, Silvia Ramos-Campoy, Joanna Kamaso, et al.
Leukemia & Lymphoma|July 22, 2017
Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemiaIsabel González-Gascón Y Marín, María Hernández-Sanchez, Ana Eugenia Rodríguez-Vicente, et al.
Hematological Oncology|February 18, 2015
A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemiaIsabel González-Gascón Y Marín, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, et al.
Hemasphere|January 30, 2026
Unveiling relative lymphopenia and elevated monocyte-to-lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)-Proposal of the objective prognostic index for CMML (OPIC)Xavier Calvo, Abora Rial-Villavecchia, David Roman-Bravo, et al.
British Journal of Haematology|July 23, 2013
Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletionAnna Puiggros, Julio Delgado, Ana Rodriguez-Vicente, et al.
Haematologica|March 11, 2021
Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patientsSilvia Ramos-Campoy, Anna Puiggros, Sílvia Beà, et al.
Pageof 5